Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune ResponsesCancer cell, 2016-09, Vol.30 (3), p.391-403 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2016.06.025 ;PMID: 27622332Full text available |
|
2 |
Material Type: Article
|
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic DiseaseCancer discovery, 2016-12, Vol.6 (12), p.1382-13992016 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-16-0577 ;PMID: 27663893Full text available |
|
3 |
Material Type: Article
|
Molecular Pathways: Targeting CD96 and TIGIT for Cancer ImmunotherapyClinical cancer research, 2016-11, Vol.22 (21), p.5183-5188 [Peer Reviewed Journal]2016 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-16-0933 ;PMID: 27620276Full text available |
|
4 |
Material Type: Article
|
Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environmentPloS one, 2015-03, Vol.10 (3), p.e0119483-e0119483 [Peer Reviewed Journal]COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Blake et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Blake et al 2015 Blake et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0119483 ;PMID: 25741704Full text available |
|
5 |
Material Type: Article
|
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsNature immunology, 2017-09, Vol.18 (9), p.1004-1015 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2017 ;Springer Nature America, Inc. 2017. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/ni.3800 ;PMID: 28759001Full text available |
|
6 |
Material Type: Article
|
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyCancer discovery, 2016-04, Vol.6 (4), p.446-4592016 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-15-0944 ;PMID: 26787820Full text available |
|
7 |
Material Type: Article
|
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of CancerCancer research (Chicago, Ill.), 2016-09, Vol.76 (18), p.5288-5301 [Peer Reviewed Journal]2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-16-0194 ;PMID: 27503925Full text available |
|
8 |
Material Type: Article
|
Advancing translational research for colorectal immuno-oncologyBritish journal of cancer, 2023-10, Vol.129 (9), p.1442-1450 [Peer Reviewed Journal]2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02392-x ;PMID: 37563222Full text available |
|
9 |
Material Type: Article
|
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich TumorCancer research (Chicago, Ill.), 2016-11, Vol.76 (21), p.6266-6277 [Peer Reviewed Journal]2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-16-2141 ;PMID: 27634762Full text available |
|
10 |
Material Type: Article
|
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccinesThe Journal of clinical investigation, 2023-09, Vol.133 (17) [Peer Reviewed Journal]COPYRIGHT 2023 American Society for Clinical Investigation ;2023 Stevens et al. 2023 Stevens et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI171742 ;PMID: 37471143Full text available |
|
11 |
Material Type: Article
|
The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later lifeCell reports (Cambridge), 2021-08, Vol.36 (8), p.109564-109564, Article 109564 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2021.109564 ;PMID: 34433065Full text available |
|
12 |
Material Type: Article
|
Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate changePloS one, 2017-07, Vol.12 (7), p.e0181333-e0181333 [Peer Reviewed Journal]COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Ellis-Soto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Ellis-Soto et al 2017 Ellis-Soto et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0181333 ;PMID: 28727747Full text available |
|
13 |
Material Type: Article
|
CD96 Is an Immune Checkpoint That Regulates CD8 + T-cell Antitumor FunctionCancer immunology research, 2019-04, Vol.7 (4), p.559-571 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 2326-6066 ;EISSN: 2326-6074 ;DOI: 10.1158/2326-6066.CIR-18-0637 ;PMID: 30894377Full text available |
|
14 |
Material Type: Article
|
Megafauna extinction, tree species range reduction, and carbon storage in Amazonian forestsEcography (Copenhagen), 2016-02, Vol.39 (2), p.194-203 [Peer Reviewed Journal]2015 Nordic Society Oikos ;Ecography © 2016 Nordic Society Oikos ;2016. This work is published under https://onlinelibrary.wiley.com/terms-and-conditions (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0906-7590 ;EISSN: 1600-0587 ;DOI: 10.1111/ecog.01587Full text available |
|
15 |
Material Type: Article
|
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisOncoimmunology, 2018-07, Vol.7 (7), p.e1445949-e1445949 [Peer Reviewed Journal]2018 Taylor & Francis Group, LLC 2018 ;2018 Taylor & Francis Group, LLC 2018 Taylor & Francis Group, LLC ;ISSN: 2162-4011 ;ISSN: 2162-402X ;EISSN: 2162-402X ;DOI: 10.1080/2162402X.2018.1445949 ;PMID: 29900061Full text available |
|
16 |
Material Type: Article
|
Forest Elephants: Tree Planters of the CongoBiotropica, 2009-07, Vol.41 (4), p.459-468 [Peer Reviewed Journal]Copyright 2009 Association for Tropical Biology and Conservation Inc. ;2009 The Author(s). Journal compilation © 2009 by The Association for Tropical Biology and Conservation ;2009 INIST-CNRS ;ISSN: 0006-3606 ;EISSN: 1744-7429 ;DOI: 10.1111/j.1744-7429.2009.00512.x ;CODEN: BTROAZFull text available |
|
17 |
Material Type: Article
|
Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in MiceCell host & microbe, 2018-05, Vol.23 (5), p.653-660.e5 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.04.009 ;PMID: 29746836Full text available |
|
18 |
Material Type: Article
|
Invasion by Cedrela odorata threatens long distance migration of Galapagos tortoisesEcology and evolution, 2024-02, Vol.14 (2), p.e10994-n/a [Peer Reviewed Journal]2024 The Authors. published by John Wiley & Sons Ltd. ;2024 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-7758 ;EISSN: 2045-7758 ;DOI: 10.1002/ece3.10994 ;PMID: 38357592Full text available |
|
19 |
Material Type: Article
|
OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in miceFASEB bioAdvances, 2021-10, Vol.3 (10), p.829-840 [Peer Reviewed Journal]2021 The Authors. published by Wiley Periodicals LLC on behalf of The Federation of American Societies for Experimental Biology ;2021 The Authors. FASEB BioAdvances published by Wiley Periodicals LLC on behalf of The Federation of American Societies for Experimental Biology. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2573-9832 ;EISSN: 2573-9832 ;DOI: 10.1096/fba.2021-00039 ;PMID: 34632317Full text available |
|
20 |
Material Type: Article
|
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapyJournal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001687 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-001687 ;PMID: 33199513Full text available |